क्यूआर कोड

P085 | ASXL1 MUTATIONS DETERMINE INFERIOR OUTCOME IN LOWER-RISK MYELODYSPLASTIC SYNDROMES:MONOCENTRIC REAL-LIFE DATA

The management of lower-risk myelodysplastic syndromes (LR-MDS), defined by IPSS-R as very low,low and intermediate-risk categories, is focused on the treatment of cytopenias, with the aim of improving quality of life and risk of disease progression. IPSS-molecular (M) has shown to provide better r...

पूर्ण विवरण

में बचाया:
मुख्य लेखकों: D. Barraco, A. Castelli, F. Orsini, E. Meroni, N. Callegari, L. Bertù, R. Righi, C.M. Basilico, M. Coscia
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Ferrata Storti Foundation 2025-09-01
श्रृंखला:Haematologica
ऑनलाइन पहुंच:https://haematologica.org/article/view/12482
टैग: टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन